Cornerstone Planning Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-518
Closed -$22.3K – 377
2026
Q2
$22.3K Buy
518
+25
+5% +$1.36K ﹤0.01% 641
2026
Q1
$27.6K Buy
493
+122
+33% +$9.8K ﹤0.01% 570
2025
Q4
$34.8K Sell
371
-170
-31% -$16.7K 0.01% 434
2025
Q3
$54.4K Buy
541
+225
+71% +$23.3K 0.01% 322
2025
Q2
$33.1K Buy
316
+67
+27% +$6.78K 0.01% 310
2025
Q1
$24.6K Buy
249
+50
+25% +$5.04K 0.01% 368
2024
Q4
$20.4K Sell
199
-2
-1% -$176 0.01% 306
2024
Q3
$17K Sell
201
-91
-31% -$7.17K ﹤0.01% 324
2024
Q2
$21.3K Sell
292
-55
-16% -$4.03K 0.01% 307
2024
Q1
$25.3K Hold
347
– – 0.01% 266
2023
Q4
$20.1K Hold
347
– – 0.01% 316
2023
Q3
$18.3K Buy
+347
New +$18.2K 0.01% 322

Other funds holding BSX

Cornerstone Planning Group's BSX Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 518 shares — an estimated $22.3K sold.

Cornerstone Planning Group first reported a position in BSX in Q3 2023 and held it in 12 quarters. The position peaked at $54.4K in Q3 2025. 335 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 518 Boston Scientific shares in Q3 2026, an estimated $22.3K.
  • Cornerstone Planning Group first reported a position in Boston Scientific in Q3 2023 and held it in 12 quarters.
  • Cornerstone Planning Group's Boston Scientific position peaked at $54.4K in Q3 2025.
  • 335 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.